Table 4.

Information reported to clinicians for CF samples

Information included in the laboratory report	No. of centers (%)
Isolated species	17 (100)
Antibiotic susceptibility	17 (100)
Use of different MIC interpretation for inhaled antibioticsa	5 (29)
Total count of microorganisms	3 (18)
Individual count of each species	11 (65)
P. aeruginosa morphotype	16 (94)
P. aeruginosa hypermutable trait	4 (24)
S. aureus SCVs	4 (24)

MICs: Minimal inhibitory concentrations; SCVs: Small-colony variants.

^aInhaled tobramycin breakpoints for P. aeruginosa: Susceptible (≤64 μg/mL) or resistant (>64 μg/mL).